"This is the beginning of a new era for us in Canada as we begin together with ESBE Scientific to provide Canadian Clinical Molecular Laboratories with automated, commercially prepared test kits for a variety of PGx testing demands. Generating this critical test information is now only possible with time-consuming and technique-dependent sequencing methodologies oriented more to research settings. We wish to enable easy access of these powerful genetic testing results by regional healthcare agencies and physicians across Canada," said Mr. Fareed Kureshy, President and CEO of AutoGenomics. He further said that "with increasing demands for alternative technologies to meet the evolving need for genotyping we are excited that we can offer an automated solution which significantly enhances workflow efficiency in the laboratory."
“We are pleased to deliver these coagulation related PGx practical DNA test solutions to our Canadian hospital reference laboratory clientele and look forward to expanding this initial Health Canada approved test kit menu to include Cancer PGx, Pain Management PGx along with Infectious Disease assay solutions,” said Laurel Wiseman, President of ESBE Scientific, Markham, Ontario - Authorized AutoGenomics Canadian Systems Distributor.
About AutoGenomics
AutoGenomics Inc., a privately held company based in Vista, CA, has developed the first automated, microarray based multiplexing diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine.
www.autogenomics.com
Contacts
AutoGenomics
Ram Vairavan
Senior Vice President Sales & Marketing
760-477-2248 x 305
rvairavan@autogenomics.com
